169 related articles for article (PubMed ID: 36463958)
21. Tryptophan catabolites and depression in the general population: results from the Gutenberg Health Study.
Michal M; Schulz A; Wild PS; Koeck T; Münzel T; Schuster AK; Strauch K; Lackner K; Süssmuth SD; Niessen HG; Borta A; Allers KA; Zahn D; Beutel ME
BMC Psychiatry; 2023 Jan; 23(1):27. PubMed ID: 36631760
[TBL] [Abstract][Full Text] [Related]
22. Maternal Tryptophan Catabolites and Insulin Resistance Parameters in Preeclampsia.
Jasim ZA; Al-Hakeim HK; Zolghadri S; Stanek A
Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892130
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan breakdown and cognition in bipolar disorder.
Platzer M; Dalkner N; Fellendorf FT; Birner A; Bengesser SA; Queissner R; Kainzbauer N; Pilz R; Herzog-Eberhard S; Hamm C; Hörmanseder C; Maget A; Rauch P; Mangge H; Fuchs D; Zelzer S; Schütze G; Moll N; Schwarz MJ; Mansur RB; McIntyre RS; Reininghaus EZ
Psychoneuroendocrinology; 2017 Jul; 81():144-150. PubMed ID: 28482311
[TBL] [Abstract][Full Text] [Related]
24. Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression.
Comai S; Melloni E; Lorenzi C; Bollettini I; Vai B; Zanardi R; Colombo C; Valtorta F; Benedetti F; Poletti S
Eur Neuropsychopharmacol; 2022 Feb; 55():96-109. PubMed ID: 34847455
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis.
Cao B; Chen Y; Ren Z; Pan Z; McIntyre RS; Wang D
Neurosci Biobehav Rev; 2021 Apr; 123():203-214. PubMed ID: 33513412
[TBL] [Abstract][Full Text] [Related]
26. Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder.
Yun Y; Zhang Q; Zhao W; Ma T; Fan H; Bai L; Ma B; Qi S; Wang Z; An H; Yang F
J Psychosom Res; 2022 Dec; 163():111069. PubMed ID: 36335711
[TBL] [Abstract][Full Text] [Related]
27. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
28. The immune-kynurenine pathway in social anxiety disorder.
Butler MI; Long-Smith C; Moloney GM; Morkl S; O'Mahony SM; Cryan JF; Clarke G; Dinan TG
Brain Behav Immun; 2022 Jan; 99():317-326. PubMed ID: 34758380
[TBL] [Abstract][Full Text] [Related]
29. Electroconvulsive therapy suppresses the neurotoxic branch of the kynurenine pathway in treatment-resistant depressed patients.
Schwieler L; Samuelsson M; Frye MA; Bhat M; Schuppe-Koistinen I; Jungholm O; Johansson AG; Landén M; Sellgren CM; Erhardt S
J Neuroinflammation; 2016 Feb; 13(1):51. PubMed ID: 26925576
[TBL] [Abstract][Full Text] [Related]
30. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder.
Poletti S; Melloni E; Aggio V; Colombo C; Valtorta F; Benedetti F; Comai S
J Affect Disord; 2019 Dec; 259():404-412. PubMed ID: 31610997
[TBL] [Abstract][Full Text] [Related]
31. Serum kynurenic acid is reduced in affective psychosis.
Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
[TBL] [Abstract][Full Text] [Related]
32. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.
Savitz J; Drevets WC; Smith CM; Victor TA; Wurfel BE; Bellgowan PS; Bodurka J; Teague TK; Dantzer R
Neuropsychopharmacology; 2015 Jan; 40(2):463-71. PubMed ID: 25074636
[TBL] [Abstract][Full Text] [Related]
33. Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects.
Müller N; Myint AM; Schwarz MJ
Curr Pharm Des; 2011; 17(2):130-6. PubMed ID: 21361867
[TBL] [Abstract][Full Text] [Related]
34. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
[TBL] [Abstract][Full Text] [Related]
35. The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites.
Bartoli F; Cioni RM; Callovini T; Cavaleri D; Crocamo C; Carrà G
Schizophr Res; 2021 Jun; 232():61-62. PubMed ID: 34015557
[No Abstract] [Full Text] [Related]
36. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
Kanchanatawan B; Maes M
CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
[TBL] [Abstract][Full Text] [Related]
37. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
[TBL] [Abstract][Full Text] [Related]
38. The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder.
Öztürk M; Yalın Sapmaz Ş; Kandemir H; Taneli F; Aydemir Ö
Int J Clin Pract; 2021 Apr; 75(4):e13739. PubMed ID: 32997876
[TBL] [Abstract][Full Text] [Related]
39. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies.
Inam ME; Fernandes BS; Salagre E; Grande I; Vieta E; Quevedo J; Zhao Z
Braz J Psychiatry; 2023 May; 45(4):343-55. PubMed ID: 37127280
[TBL] [Abstract][Full Text] [Related]
40. Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid.
Fukuwatari T
Nutrients; 2020 May; 12(5):. PubMed ID: 32414200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]